Adhesion-dependent multicellular drug resistance

Anti-Cancer Drug Design

Volumn 14, Issue 2, 1999, Pages 153-168

  Green, Shane K ^a,b   Frankel, Andrea ^a,c   Kerbel, Robert S ^a,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adhesion; Anti adhesives; Ascites; Drug resistance; Multicellular tumor spheroids; Ovarian cancer

Indexed keywords

AMINE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL;

ADVANCED CANCER; ASCITES TUMOR; CELL ADHESION; CELL CULTURE; CLINICAL TRIAL; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; ASCITES; CELL ADHESION; CELL CYCLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 0033012394     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (129)

1. Akahani S., Nangia-Makker P., Inohara H., Kim H.R., Raz A. (1997) Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Research, 57, 5272.
2. Alberts D.S., Liu P.Y., Hannigan E.V., O'Toole R., Williams S.D., Young J.A., Franklin E.W., Clarke-Pearson D.L., Malviya V.K., Dubeshter B. (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. New England Journal of Medicine, 335, 1950.
3. Allen H.J., Porter C., Gamarra M., Piver M.S., Johnson E.A. (1987) Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions. Experimental Cell Biology, 55, 194.
4. Assoian R.K., Marcantonio E.E. (1996) The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. Journal of Clinical Investigation, 98, 2436.
5. Auersperg N., Maines-Bandiera S.L., Dyck H.G., Kruk P.A. (1994) Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Laboratory Investigations, 71, 510.
6. Barry M.A., Behinke C.A., Eastman A. (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochemical Pharmacology, 40, 2353.
7. Bates R.C., Buret A., van Helden D.F., Horton M.A., Burns G.F. (1994) Apoptosis induced by inhibition of intercellular contact. Journal of Cell Biology, 125, 403.
8. Behrens J., von Kries J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. (1996) Functional interaction of β-catenin with the transcription factor LEF-1. Nature, 382, 638.
9. Bhuyan B.K., Folz S.J., Dezwaan J., Northcott S.E., Alberts D.S., Garcia D., Wallace T.L., Li L.H. (1991) Cytotoxicity of tetraplatin and cisplatin for human and rodent cell lines cultured as monolayers and multicellular spheroids. Cancer Communications, 3, 53.
10. Bjorge L., Junnikkala S., Kristoffersen E.K., Hakulinen J., Matre R., Meri S. (1997) Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis. British Journal of Cancer, 75, 1247.
11. Boehm T. (1998) An old paradigm for treating cancer and other diseases in the 21st century. Cancer Metastasis Reviews, 17, 149.
12. Brady-Kalnay S.M., Flint A.J., Tonks N.K. (1993) Homophilic binding of PTPμ, a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation. Journal of Cell Biology, 122, 961.
13. Brown J.M., Giaccia A.J. (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Research, 58, 1408.
14. Cepek K.L., Shaw S.K., Parker C.M., Russell G.J., Morrow J.S., Rimm D.L., Brenner M.B. (1994) Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature, 372, 190.
15. Chignola R., Foroni R., Franceschi A., Pasti M., Candiani C., Anselmi C., Fracasso G., Tridente G., Colombatti M. (1995) Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin. British Journal of Cancer, 72, 607.
16. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650.
17. Davies B.R., Worsley S.D., Ponder B.A. (1998) Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology, 32, 69.
18. Dimanche-Boitrel M.T., Genne P., Duchamp O., Chauffert B. (1994) Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells. Cancer Letters, 85, 171.
19. Durand R.E., Sutherland R.M. (1972) Effects of intercellular contact on repair of radiation damage. Experimental Cell Research, 71, 75.
20. Eastman A. (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2, 275.
21. Eijgenraam F. (1993) Things start getting sticky for a cell surface enzyme. Science, 261, 833.
22. Endicott J.A., Ling V. (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry, 58, 137.
23. Erlichman C., Vidgen D., Wu A. (1985) Cytotoxicity of cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate in MGH-U1 cells grown in monolayers, spheroids, and xenografts. Journal of the National Cancer Institute, 75, 499.
24. Fang F., Orend G., Watanabe N., Hunter T., Ruoslaht E. (1996) Dependence of cyclin E-Cdk2 kinase activity on cell anchorage. Science, 271, 499.
25. 2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Research, 57, 2388.
26. Freireich E.J. (1993) Treatment of malignancies, past and present. Hospital Practice, 28, 109.
27. Frisch S.M., Francis H. (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. Journal of Cell Biology, 124, 619.
28. Gebbink M.F., Zondag G.C., Koningstein G.M., Feiken E., Wubbolts R.W., Moolenaar W.H. (1995) Cell surface expression of receptor protein tyrosine phosphatase RPTP mu is regulated by cell-cell contact. Journal of Cell Biology, 131, 251.
29. Glinsky G.V. (1989) Glycoamines. Biochemistry of a new class of humoral tumor markers. Journal of Tumor Marker Oncology, 4, 193.
30. Glinsky G.V. (1992a) Glycoamines. Structural-functional characterization of a new class of humoral tumor markers. In Serological Cancer Markers. Sell S. (ed.), p. 233. The Humana Press: Totowa, NJ.
31. Glinsky G.V. (1992b) The blood group antigen-related glycoepitopes: key structural determinants in immunogenesis and AIDS pathogenesis. Medical Hypotheses, 39, 212.
32. Glinsky G.V. (1993a) Glycodeterminants of melanoma cell adhesion: a model for antimetastatic drugs design. Critical Reviews in Oncology and Hematology, 14, 1.
33. Glinsky G.V. (1993b) Cell adhesion and metastasis: is the site specificity of cancer metastasis determined by leukocyte-endothelial cell recognition and adhesion? Critical Reviews in Oncology and Hematology, 14, 229.
34. Glinsky G.V. (1997) Apoptosis in metastatic cancer cells. Critical Reviews in Oncology and Hematology, 25, 175.
35. Glinsky G.V. (1998) Anti-adhesion cancer therapy. Cancer Metastasis Reviews, 17, 177.
36. Glinsky G.V., Glinsky V.V. (1996) Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Letters, 101, 43.
37. Glinsky G.V., Linetsky M.D. (1990) Structural analysis of the carbohydrate core of amino-glycoconjugates (glycoamines) from blood plasma of oncological patients. Journal of Tumor Marker Oncology, 5, 137.
38. Glinsky G.V., Linetsky M.D., Liventsov V.V., Surmilo N.I., Ivanova A.B., Sidorenko M.V., Vinnitsky V.B. (1990) Glycoamine-synthesizing reaction: molecular mechanism of the incorporation of monomers into aminoglycoconjugates. Journal of Tumor Marker Oncology, 5, 119.
39. Glinsky G.V., Mossine V.V., Price J.E., Bielenberg D., Glinsky V.V., Ananthaswamy H.N., Feather M.S. (1996a) Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs. Clinical Experimental Metastasis, 14, 253.
40. Glinsky G.V., Price J.E., Glinsky V.V., Mossine V.V., Kiriakova G., Metcalf J.B. (1996b) Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Cancer Research, 56, 5319.
41. Gong J., Ko T.C., Brattain M.G. (1998) Disruption of fibronectin binding to the alpha 5 beta 1 integrin stimulates the expression of cyclin-dependent kinases and DNA synthesis through activation of extracellular signal-regulated kinase. Journal of Biological Chemistry, 273, 1662.
42. Gorlach A., Herter P., Hentschel H., Frosch P.J., Acker H. (1994) Effects of nIFN β and rIFN gamma on growth and morphology of two human melanoma cell lines: comparison between two-and three-dimensional culture. International Journal of Cancer, 56, 249.
43. Graham C.H., Kobayashi H., Stankiewicz K.S., Man S., Kapitain S.J., Kerbel R.S. (1994) Rapid acquisition of multicellular drug resistance after a single transient exposure of mammary tumor cells to alkylating agents. Journal of the National Cancer Institute, 86, 975.
44. Hague A., Hicks D.J., Bracey T.S., Paraskeva C. (1997) Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factors protect against c-myc-independent apoptosis. British Journal of Cancer, 75, 960.
45. Hannigan G.E., Dedhar S. (1997) Protein kinase mediators of integrin signal transduction. Journal of Molecular Medicine, 75, 35.
46. Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G., Radeva G., Filmus J., Bell J.C., Dedhar S. (1996) Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature, 379, 91.
47. Hengst L., Dulic V., Slingerland J.M., Lees E., Reed S.I. (1994) A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proceedings of the National Academy of Sciences, USA, 91, 5291.
48. Hermiston M.L., Gordon J.I. (1995) In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenace of differentiation, and regulation of programmed cell death. Journal of Cell Biology, 129, 489.
49. Hinck L., Nathke I.S., Papkoff J., Nelson W.J. (1994) Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. Journal of Cell Biology, 125, 1327.
50. Hoschuetzky H., Aberle H., Kemler R. (1994) Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. Journal of Cell Biology, 127, 1375.
51. Houghton P.J., Kaye S.B. (1994) Multidrug resistance is not an important factor in therapeutic outcome in human malignancies. Journal of NIH Research, 6, 55.
52. Hynes R.O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11.
53. Joseph-Silverstein J., Silverstein R.L. (1998) Cell adhesion molecules: an overview. Cancer Investigation, 16, 176.
54. Kammerer R., von Kleist S. (1995) The influence of the local environment on tissue architecture of colorectal carcinoma (CRC) cell aggregates and its consequence for tumour attack by lymphocytes in vitro and in vivo. European Journal of Cancer, 31A, 2324.
55. Kantak S.S., Kramer R.H. (1998) E-Cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. Journal of Biological Chemistry, 273, 16953.
56. Kartner N., Riordan J.R., Ling V. (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221, 1285.
57. Kerbel R.S. (1991) Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. BioEssays, 13, 31.
58. Kerbel R.S. (1997) A cancer therapy resistant to resistance. Nature, 390, 335.
59. Kerbel R.S., St Croix B., Rak J., Graham C. (1995) Is there a role for 'anti-adhesives' as chemosensitizers in the treatment of solid tumors by chemotherapy? Bulletin de l'Institut Pasteur, 92, 248.
60. Kishida S., Yamamoto H., Ikeda S., Kishida M., Sakamoto I., Koyama S., Kikuchi A. (1998) Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. Journal of Biological Chemistry, 273, 10823.
61. Kitsuki H., Katano M., Morisaki T., Torisu M. (1995) CEA-mediated homotypic aggregation of human colorectal carcinoma cells in a malignant effusion. Cancer Letters, 88, 7.
62. Knudsen K.A., Soler A.P., Johnson K.R., Wheelock M.J. (1995) Interaction of alpha-actinin with the cadherin/ catenin cell-cell adhesion complex via alpha-catenin. Journal of Cell Biology, 130, 67.
63. Kobayashi H., Man S., Kapitain S.J., Teicher B.A., Kerbel R.S. (1993) Acquired multicellular-mediated resistance to alkylating agents in cancer. Proceedings of the National Academy of Sciences, USA, 90, 3294.
64. Kuo K.C., Gehrke J.C., Allen W.C., Holsbeke M., Li Z., Glinsky G.V., Zumwalt R.W., Gehrke C.W. (1994) High-performance liquid chromatographic analysis of glycoamines in serum. Journal of Chromatography, B. Biomedical Applications, 656, 295.
65. LaRue K.E., Bradbury E.M., Freyer J.P. (1998) Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts. Cancer Research, 58, 1305.
66. Levenberg S., Yarden A., Kam Z., Geiger B. (1999) p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry. Oncogene, 18, 869.
67. Los G., Mutsaers P.H., van der Vijgh W.J., Baldew G.S., de Graaf P.W., McVie J.G. (1989) Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Research, 49, 3380.
68. Ma M., Eaton J.W. (1992) Multicellular oxidant defense in unicellular organisms. Proceedings of the National Academy of Sciences, USA, 89, 7924.
69. Mareel M., Boterberg T., Noe V., van Hoorde L., Vermeulen S., Bruyneel E., Bracke M. (1997) E-Cadherin/catenin/ cytoskeleton complex: a regulator of cancer invasion. Journal of Cellular Biochemistry, 173, 271.
70. Markman M., Francis P., Rowinsky E., Hoskins W. (1995) Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer? Seminars in Oncology, 22, 84.
71. Martin S.J., Green D.R. (1994) Apoptosis as a goal of cancer therapy. Current Opinion in Cell Biology, 6, 616.
72. Marx J. (1993) Cell death studies yield cancer clues. Science, 259, 760.
73. Matsumura T., Wolff K., Petzelbauer P. (1997) Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. Journal of Immunology, 158, 3408.
74. Meredith J.E. Jr, Fazeli B., Schwartz M.A. (1993) The extracellular matrix as a cell survival factor. Molecular Biology of the Cell, 4, 953.
75. Miller B.E., Miller F.R., Heppner G.H. (1985) Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Research, 45, 4200.
76. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proceedings of the National Academy of Sciences, USA, 91, 8856.
77. Nahhas W.A. (1997) Ovarian cancer. Current outlook on this deadly disease. Postgraduate Medicine, 102, 112.
78. KipI display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85, 707.
79. Novak A., Hsu S.C., Leung-Hagesteijn C., Radeva G., Papkoff J., Montesano R., Roskelley C., Grosschedl R., Dedhar S. (1998) Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proceedings of the National Academy of Sciences, USA, 95, 4374.
80. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane S.W., Cao Y., Sage E.H., Folkman J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79, 315.
81. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277.
82. Ochiai A., Akimoto S., Kanai Y., Shibata T., Oyama T., Hirohashi S. (1994) c-erbB-2 gene product associates with catenins in human cancer cells. Biochemical and Biophysical Research Communications, 205, 73.
83. Ohshima S., Ishimaru Y., Honda M., Ohkawara S., Ogawa M. (1993) A monoclonal antibody disrupting cell-cell adhesion of rat ascites hepatoma cells. Cell Tissue Research, 273, 363.
84. Olive P.L., Durand R.E. (1994) Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Reviews, 13, 121.
85. Ozols R.F., Vermorken J.B. (1997) Chemotherapy of advanced ovarian cancer: current status and future directions. Seminars in Oncology, 24, S2.
86. Peluso J.J., Pappalardo A., Trolice M.P. (1996) N-Cadherin-mediated cell contact inhibits granulosa cell apoptosis in a progesterone-independent manner. Endocrinology, 137, 1196.
87. Pilon A.A., Nieves-Neira W., Pourquier P., Rong-Guang S., Pommier Y. (1998) Induction of E2F-1 in drug-induced apoptosis in the human HT29 colon carcinoma cell line. Proceedings of the American Association of Cancer Research, 39, 69.
88. Piver M.S., Recio F.O., Baker T.R., Driscoll D. (1994) Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer. Cancer, 73, 1693.
89. KipI, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Development, 8, 9.
90. Puls L.E., Duniho T., Hunter J.E. IV, Kryscio R., Blackhurst D., Gallion H. (1996) The prognostic implication of ascites in advanced-stage ovarian cancer. Gynecologic Oncology, 61, 109.
91. Raff M. (1992) Social controls on cell survival and cell death. Nature, 356, 397.
92. Rasey J.S., Cornwell M.M., Maurer B.J., Boyles D.J.S., Hofstrand P., Chin L., Cerveny C. (1996) Growth and radiation response of cells grown in macroporous gelatin microcarriers (CultiSpher-G™). British Journal of Cancer, 74, S78.
93. Roberts J.M., Koff A., Polyak K., Firpo E., Collins S., Ohtsubo M., Massague J. (1994) Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harbor Symposium on Quantitative Biology, 59, 31.
94. Rosato R., Veltmaat J.M., Groffen J., Heisterkamp N. (1998) Involvement of the tyrosine kinase fer in cell adhesion. Molecular and Cellular Biology, 18, 5762.
95. Rubin C. (1993) Monoclonal antibodies in the management of ovarian cancer. A clinical perspective. Cancer, 71, 1602.
96. Rubinfeld B., Souza B., Albert I., Muller O., Chamberlain S.H., Masiarz F.R., Munemitsu S., Polakis P. (1993) Association of the APC gene product with beta-catenin. Science, 262, 1731.
97. Ruoslahti E., Pierschbacher M.D. (1987) New persepctives in cell adhesion: RGD and integrins. Science, 238, 491.
98. Sakata K., Kwok T.T., Gordon G.R., Waleh N.S., Sutherland R.M. (1994) Resistance to verapamil sensitization of multidrug resistant cells grown as multicellular spheroids. International Journal of Cancer, 59, 282.
99. Schneider J.G. (1994) Intraperitoneal chemotherapy. Obstetrics and Gynecology Clinics in North America, 21, 195.
100. Sergeeva N.S., Chissov V.I., Sviridova I.K. (1995) Re: rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. Journal of the National Cancer Institute, 87, 687.
101. 1 cyclin-dependent kinases. Genes Development, 9, 1149.
102. Shweiki D., Neeman M., Itin A., Keshet E. (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proceedings of the National Academy of Sciences, USA, 92, 768.
103. Skladanowski A., Konopa J. (1998) Abrogation of transient S phase arrest induced by a new drug imidacrine decreases its cytotoxic activity toward HT-29 colon carcinoma cells. Proceedings of the American Association of Cancer Research, 39, 68.
104. St Croix B., Kerbel R.S. (1997) Cell adhesion and drug resistance in cancer. Current Opinion in Cell Biology, 9, 549.
105. KipI on adhesion-dependent resistance of tumor cells to anticancer agents. Nature Medicine, 2, 1204.
106. St Croix B., Rak J.W., Kapitain S., Sheehan C., Graham C.H., Kerbel R.S. (1996b) Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells. Journal of the National Cancer Institute, 88, 1285.
107. KIPI. Journal of Cell Biology, 142, 557.
108. Su L.K., Vogelstein B., Kinzler K.W. (1993) Association of the APC tumor suppressor protein with catenins. Science, 262, 1734.
109. Sutherland R.M. (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science, 240, 177.
110. Sutherland R.M., McCredie J.A., Inch W.R. (1971) Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. Journal of the National Cancer Institute, 46, 113.
111. Takahashi K., Suzuki K. (1996) Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Experimental Cell Research, 226, 214.
112. Takeichi M. (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251, 1451.
113. Tannock I.F. (1994) Principles of cell proliferation: cell kinetics. In Current Cancer Therapeutics. Anonymous, p. 3. Princeton Academic Press: Princeton, NJ.
114. Teicher B.A., Herman T.S., Holden S.A., Wang Y., Pfeffer M.R., Crawford J.W., Frei E. III (1990) Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science, 247, 1457.
115. Twentyman P.R. (1980) Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival. British Journal of Cancer, 42, 297.
116. Vallorosi C.J., Powell C.T., Day M.L. (1998) E-Cadherin mediates aggregation-dependent survival of prostate epithelial cells. Proceedings of the American Association of Cancer Research, 39.
117. Vaux D.L. (1993) Towards an understanding of the molecular mechanisms of physiological cell death. Proceedings of the National Academy of Sciences, USA, 90, 786.
118. Vleminckx K., Vakaet L. Jr, Mareel M., Fiers W., van Roy F. (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107.
119. Volm M., Koomagi R., Mattern J. (1996) Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. Anticancer Research, 16, 213.
120. Volm M., Koomagi R., Mattern J., Stammler G. (1997) Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Research, 17, 99.
121. Waldman T., Lengauer C., Kinzler K.W., Vogelstein B. (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature, 381, 713.
122. Waleh N.S., Gallo J., Grant T.D., Murphy B.J., Kramer R.H., Sutherland R.M. (1994) Selective down-regulation of integrin receptors in spheroids of squamous cell carcinoma. Cancer Research, 54, 838.
123. Wang J., Walsh K. (1996) Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation. Science, 273, 359.
124. Wartenberg M., Frey C., Diedershagen H., Ritgen J., Hescheler J., Sauer H. (1998) Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids. International Journal of Cancer, 75, 855.
125. Wary K.K., Mainiero F., Isakoff S.J., Marcantonio E.E., Giancotti F.G. (1996) The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell, 87, 733.
126. Watabe M., Nagafuchi A., Tsukita S., Takeichi M. (1994) Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. Journal of Cell Biology, 127, 247.
127. Whitacre C.M., Berger N.A. (1997) Factors affecting topotecan-induced programmed cell death: adhesion protects cells from apoptosis and impairs cleavage of poly(ADP-ribose) polymerase. Cancer Research, 57, 2157.
128. Yang R.Y., Hsu D.K., Liu F.T. (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proceedings of the National Academy of Sciences, USA, 93, 6737.
129. Zhu X., Ohtsubo M., Mohmer R.M., Roberts J.M., Assoian R.K. (1996) Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. Journal of Cell Biology, 133, 391.